期刊文献+

人乳腺癌OX40L转基因细胞株的构建及其对T细胞的共刺激作用 被引量:2

Construction of Human Breast Carcinoma Cell Line Transfected with OX40L and Its Costimulatory Effect on T Cells
下载PDF
导出
摘要 背景与目的:共刺激分子OX40(CD134)和OX40配体(OX40L、CD134L)分属TNFR、TNF家族,OX40-OX40L信号能促进细胞因子的产生及提高抗原特异性记忆T细胞的数量,发挥重要的免疫调节作用。本实验旨在构建稳定表达OX40配体(OX40L)的人乳腺癌转基因细胞株,进而研究OX40-OX40L信号对T细胞体外活化和功能的调节作用。方法:运用逆转录聚合酶链反应(RT-PCR)技术从人成熟树突细胞(dendriticcell,DC)获得全长人OX40L基因,构建真核表达载体pcDNA3.1-OX40L转染人乳腺癌细胞株MDA-MB-435;经过G418抗性筛选和亚克隆,获得稳定表达OX40L的转基因细胞,并经RT-PCR和免疫荧光标记确证靶分子的表达;采用MTT、酶联免疫吸附试验(ELISA)和免疫荧光标记等方法分析转基因细胞对T细胞的增殖、IL-2、IL-4、IFN-γ的分泌和T细胞上Fas分子表达的影响。结果:成功地获得稳定表达人OX40L分子的人乳腺癌MDA-MB-435转基因细胞株,该细胞株可有效地促进T细胞增殖,促进T细胞分泌IL-2和IFN-γ,在第7天,T细胞、T细胞+M435、T细胞+M435-mock、T细胞+M435-OX40L各组IL-2的浓度依次为:315ng/ml、322ng/ml、586ng/ml、973.4ng/ml;IFN-γ浓度依次为:(2518±117.6)pg/ml、(2490±124.2)pg/ml、(2695±134.5)pg/ml、(3755±187.75)pg/ml,该基因转染细胞同时还能下调T细胞上Fas分子的表达[(68.3±5.6)%,P<0.05]。结论:稳定表达人OX40L的乳腺癌转基因细胞在体外能有效地活化T细胞,介导其增殖、分泌细胞因子及抑制T细胞活化诱导的细胞死亡。 BACKGROUND & OBJECTIVE. Costimulator OX40 (CD134) belongs to TNFR family, and its ligand OX40L (CD134L) belongs to TNF family. OX40-OX40L signal plays an important role in immune regulation, which can increase the production of cytokines and enhance the survival of antigen-specific T cells. This research was to transfect OX40L into human breast cancer cell line MDA-MB-435 to construct OX40L-MDA-MB-435 cells, and to investigate the costimulatory effect of OX40-OX40L signal on biological activity of T cells in vitro. METHODS. cDNA fragment encoding OX40L was obtained from human mature dendritic cells by reverse transcriptionpolymerase chain reaction (RT-PCR), and inserted into eukaryotic expression vector pcDNA3.1. The recombinant plasmid pcDNA3.1-OX40L was transfected into MDA-MB-435 cells, and verified by indirect immunophenotyping and RTPCR. The effect of OX40L-MDA-MB-435 cells to the biological activity of T cells was investigated by MTT, enzyme-linked immunosorbent assay (ELISA), and direct immunophenotyping. RESULTS, OX40L-MDA-MB-435 cells were successfully constructed. These cells efficiently promoted the proliferation of T cells, enhanced the secretion of interleukin-2 (IL-2) (973.4 ng/ml at the 7th day) and interferon-γ(IFN-γ) (3 689.167 pg/ml at the 3rd day), and down-regulated the expression of Fas on T cells [ (68.3±5.6)%, P〈0.05]. CONCLUSION. OX40L-MDA-MB-435 cells could activate T cells in vitro, promote T cell proliferation and cytokine secretion, and suppress T cell activation-induced cell death.
出处 《癌症》 SCIE CAS CSCD 北大核心 2006年第2期148-152,共5页 Chinese Journal of Cancer
基金 国家重点基础研究发展规划项目(No.2001CB510003)~~
关键词 乳肿肿瘤 MDA—MB-435细胞株 OX40L转基因细胞 T细胞 免疫调节 Breast neoplasms MDA-MB-435 cell line OX40L-transfected cell T cell Immune regulation
  • 相关文献

参考文献11

  • 1李国强,王学浩,印洁,俞悦.4-1BBL基因真核表达载体构建及在肝癌细胞中表达的研究[J].中华肿瘤杂志,2003,25(4):328-331. 被引量:3
  • 2Chitnis T, Khoury S J. Role of costimulatory pathways in thepathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis [J]. J Allergy Clin lmmunol,2003,112 ( 5 ) : 837-849.
  • 3Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? [J]. Nat Rev lmmunol, 2003,3(8) : 609-620.
  • 4Weatherill A R, Maxwell J R, Takahashi C, et al. OX40 ligation enhances cell eycle turnover of Ag-activated CD4 T cells in vivo [J]. Cell lmmunol, 2001,209(1) :63-75.
  • 5Baba E, Takahashi Y, Lichtenfeld J, et al. Functional CD4 T cells after intercellular molecular transfer of OX40 ligand[J]. J lmmunol, 2001,167(2):875-883.
  • 6Ohshinla Y, Yang L P, Uchiyama T, et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4 (+) T cells into high 1L-4-produeing effectors [J]. Blood,1998,92 (9) : 3338-3345.
  • 7Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper(Th)1 and Th2 cells [J]. J Exp Med, 2000, 191(2):201-206.
  • 8De Smedt T, Smith J, Baum P, et al. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo [J]. J Immunol, 2002,168(2):661-670.
  • 9Tanaka H, Demeure C E, Rubio M, et al. Human monocytederived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors [J]. J Exp Med, 2000, 192(3) :405-412.
  • 10De Jong E C, Vieira P L, Kalinski P, et al. Microbial compounds selectively induce Thl cell-promoting or Th2 cellpromoting dendritic cells in vitro with diverse the cellpolarizing signals [J]. J Immunol, 2002, 168 (4): 1704-1709.

二级参考文献12

  • 1Tan JT, Whitmire JK, Ahmed R, et al.4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol, 1999,163:4859-4868.
  • 2DeBenedette MA, Chu NR, Pollok KE, et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med, 1995,181:985-992.
  • 3Mogi S, Sakurai J, Kohsaka T, et al. Tumour rejection by gene transfer of 4-1BB ligand into a CD80( + ) murine squamous cell carcinoma and the requirements of co-stimulsatory molecules on tumour and host cells.Immunology, 2000,101 : 541-547.
  • 4Guinn BAI DeBenedette MA, Watts TH, et al. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J Immunol, 1999, 162:5003-5010.
  • 5Goodwin RG, Din WS, Davis-Smith T, et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol, 1993,23 : 2631-2641.
  • 6Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol, 1994,24:2219-2227.
  • 7Zhu G, Flies DB, Tamada K, et al. Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand/I-Ealpha)-transgenic mice. J Immunol, 2001,167:2671-2676.
  • 8Melero I, Bach N, Hellstrom KE, et al. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur J Immunol, 1998,28: 1116-1121.
  • 9Melero I, Shuford WW, Newby SA, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med, 1997,3:682-685.
  • 10Martinet O, Ennekova V, Qiao JQ, et al.Immunomodulatory gene therapy with interleukin 12 and 4-1BB hgand: long- term remission of liver metastases in a mouse model. J Nail Cancer Inst, 2000,92:931-936.

共引文献2

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部